Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of neuroinflammation, 14.2017, Nr. 1, Art. 152, doi:10.1186/s12974-017-0926-2
- Schlagwort
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2017
- Urheber
-
Stolz, Leonie
Derouiche, Amin
Devraj, Kavi
Weber, Frank
Brunkhorst, Robert
Förch, Christian
- URN
-
urn:nbn:de:hebis:30:3-457902
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stolz, Leonie
- Derouiche, Amin
- Devraj, Kavi
- Weber, Frank
- Brunkhorst, Robert
- Förch, Christian
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2017
Ähnliche Objekte (12)
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Rivaroxaban versus warfarin for the management of left ventricle thrombus
Warfarin-related nephropathy: unveiling the hidden dangers of anticoagulation
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Warfarin anticoagulation in acute type A aortic dissection survivors (WATAS)
Warfarin anticoagulation in acute type A aortic dissection survivors (WATAS)
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients
Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Rivaroxaban versus warfarin for the management of left ventricle thrombus
Warfarin-related nephropathy: unveiling the hidden dangers of anticoagulation
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Warfarin anticoagulation in acute type A aortic dissection survivors (WATAS)
Warfarin anticoagulation in acute type A aortic dissection survivors (WATAS)
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients
Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Rivaroxaban versus warfarin for the management of left ventricle thrombus
Warfarin-related nephropathy: unveiling the hidden dangers of anticoagulation
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Warfarin anticoagulation in acute type A aortic dissection survivors (WATAS)
Warfarin anticoagulation in acute type A aortic dissection survivors (WATAS)
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients
Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis